NCT06936891: VIP care

Virtual Ward for Early Discharge in Patients Receiving Inpatient Care

Recruiting now NA Last updated 17 February 2026

What this trial tests

NA trial testing Virtual Ward in Early Discharge in 306 participants. Currently enrolling.

Timeline

16 April 2025

Primary endpoint
16 October 2028

31 December 2028

Quick facts

Lead sponsor	Erasmus Medical Center
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	306
Start date	16 April 2025
Primary completion	16 October 2028
Estimated completion	31 December 2028
Sites	1 location across Netherlands

Drugs / interventions tested

• Virtual Ward

Conditions studied

• Early Discharge — all drugs for Early Discharge →
• Telemedicine — all drugs for Telemedicine →
• Virtual Clinic — all drugs for Virtual Clinic →
• Hospital at Home — all drugs for Hospital at Home →

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Early Discharge or Telemedicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Delivering hospital care at home in a Dutch Tertiary University Hospital: protocol for a prospective feasibility cohort study evaluating a Virtual Ward for early discharge of inpatients.
   van Herwerden MC, Scholte NTB, Mkrtchjan A, Feyz L, et al · · 2026 · PMID 41734918 · DOI 10.1136/bmjopen-2025-115730